RxDoctor Payments Data

Frampton Henderson, MD

Family Medicine · Columbia, SCNPI 1407802184

Payments from drug & device makers

$7,290in general payments, 2019–2025

Across 442 payments — averaging $16.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$818
  • Novo Nordisk$817
  • Lilly USA, LLC$728
  • Pfizer$456
  • Amgen$357
  • GSK$353
  • plus $4K from 42 others

What the payments were for

  • Food & beverage$7,290100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,290 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$185,034
Medicare patients
493
Services billed
21,896

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol120$122,524
EliquisApixaban90$91,459
JardianceEmpagliflozin90$81,997
RybelsusSemaglutide40$67,671
OzempicSemaglutide67$67,551
MounjaroTirzepatide30$40,090
TrulicityDulaglutide21$31,643
XareltoRivaroxaban50$30,771
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog38$20,714
JanuviaSitagliptin Phosphate18$19,210
LinzessLinaclotide16$16,086
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$15,877
Humalog Kwikpen U-100Insulin Lispro39$11,724
NeuproRotigotine12$9,949
Breo ElliptaFluticasone/Vilanterol16$7,809

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$817$135,222107 claims
AstraZenecaFarxiga$818$122,524120 claims
PfizerEliquis$456$91,45990 claims
Boehringer IngelheimJardiance$229$81,99790 claims
Lilly USA, LLCMounjaro, Trulicity$728$71,73451 claims
Johnson & JohnsonXarelto$160$30,77150 claims
GSKBreo Ellipta, Shingrix, Arexvy$353$19,28661 claims
MerckJanuvia$137$19,21018 claims
AbbVieLinzess, Synthroid$263$19,00351 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →